COVID-19
| 3 min read
A breath test to rapidly diagnose COVID-19 infection may be on the way from imec
| 2 min read
Preliminary results show safety and tolerability of AT-301 nasal spray for COVID-19
| 4 min read
PepTC reports positive preclinical results for peptide vaccine
| 3 min read
Hoth Therapeutics collaborates with USAMRDC to treat multi-drug resistant bacterial lung infections
| 2 min read
In lab experiments, pralatrexate outperformed remdesivir against SARS-CoV-2
| 2 min read
Soligenix gains a $1.5 million Small Business Innovation Research award for COVID-19 and ebola vaccines
| 3 min read
The companies will collaborate on an allogeneic cell therapy candidate for solid tumor cancers
| 2 min read
Resverlogix publishes work in PNAS detailing how BET inhibition was found to reduce SARS-CoV-2 infection in mice and human cell lines
| 3 min read
NBE-Therapeutics will remain at its Basel, Switzerland, campus and operate within Boehringer Ingelheim’s R&D network
| 2 min read
Positive initial casirivimab and imdevimab results in non-hospitalized COVID-19 patients were published in NEJM
